Youngevity's Stock Soars On Purchase Of Hemp Extraction Equipment Maker


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Youngevity International Inc (NASDAQ:YGYI) shares were trading in the green Wednesday after the company announced that it will acquire Khrysos Global, a manufacturer of extraction equipment. 

What Happened

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

The value of the deal is $16 million, which includes around 1.79 million shares of Youngevity and $500,000 in cash to be paid at the closing. In addition, Khrysos principals will receive warrants to purchase up to 3 million shares at $10 apiece upon the achievement of certain revenue and profit milestones. 

In exchange, Youngevity will acquire all of Khrysos Global's assets, including real estate, joint venture agreements, contract rights, intellectual property, trademarks, copyrights and service marks. 

Why It's Important

Khrysos Global is a Florida-based manufacturer of hemp-based CBD extraction equipment. The acquisition will allow Youngevity to establish its presence in the field-to-finish hemp-based CBD oil, isolate and distillate markets. 

Youngevity International is a lifestyle company that provides health, nutrition and other products. Last year, it announced its entry the cannabis space through the launch of the Hemp FX line that includes three hemp-derived cannabinoid products.


FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


In October, the company further expanded the line with two CBD beverages

The acquisition of Khrysos gives Youngevity access to INX Labs and testing facilities, which the company said will allow it to enhance quality control and testing standards for its CBD products. 

What's Next

The deal is expected to close Feb. 15 and is subject to various closing conditions. After the acquisition, Khrysos will provide consulting and advisory services to Youngevity. 

Youngevity shares were up 12.52 percent at $8.18 at the time of publication Wednesday. The stock earlier hit an intra-day high of $9.28.

Related Links:

Constellation Brands Made The Right Move With Early Cannabis Investment, Wells Fargo Says

Scoop: One Of America's Top Pharmaceutical Drug Directories Includes CBD Products For The First Time Ever

Photo courtesy of Youngevity. 


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: CannabisNewsM&AMarketshemp CBDKhrysos GlobalYoungevity International